Search Within

Matthew I Milowsky

Refine Results
Formats
  1. Meeting Abstract (39)
  2. Journal Article (34)
  3. Book Section (1)
Groups
  1. Genitourinary Oncology Service (56)
  2. Solid Tumor Oncology Division (56)
  3. Genitourinary Disease Management Team (49)
  4. Epidemiology and Biostatistics (18)
  5. Biostatistics Service (17)
  6. Nursing (17)

More Groups

People
  1. Dean Bajorin (45)
  2. Ashley Regazzi (18)
  3. David Gallagher (17)
  4. Hikmat Al-Ahmadie (17)
  5. Victor Reuter (14)
  6. Alisa Trout (13)

More People

Years
  1. 2016 (1)
  2. 2015 (1)
  3. 2014 (5)
  4. 2013 (5)
  5. 2012 (2)
  6. 2011 (22)

More Years

Publications
  1. Journal of Clinical Oncology (30)
  2. BJU International (6)
  3. Laboratory Investigation (6)
  4. Cancer (5)
  5. Modern Pathology (4)
  6. Journal of Urology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (30)
  2. Wiley Blackwell (12)
  3. Nature Publishing Group (10)
  4. Elsevier Science, Inc. (5)
  5. Oxford University Press (3)
  6. American Association for Cancer Research (2)

More Publishers

Results (74)

Export to EndNote | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer
    Journal Article

    Milowsky, M. I.; Galsky, M. D.; Morris, M. J.; Crona, D. J.; George, D. J.; Dreicer, R.; Tse, K.; Petruck, J.; Webb, I. J.; Bander, N. H.; more...
    Urologic Oncology: Seminars and Original Investigations (2016)

    Fulltext@MSK | Save
  • Phase I trial of gemcitabine and split-dose cisplatin plus everolimus (RAD001) in patients with advanced urothelial cancer
    Meeting Abstract

    Abida, W.; Milowsky, M. I.; Ostrovnaya, I.; Gerst, S. R.; Rosenberg, J. E.; Regazzi, A. M.; McCoy, A. S.; Boyd, M. E.; Bajorin, D. F.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma (UC) based on the impact of prognostic factors
    Meeting Abstract

    Sonpavde, G.; Bellmunt, J.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Comparative effectiveness of gemcitabine plus cisplatin (GC) versus methotrexate, vinblastine, doxorubicin, plus cisplatin (MVAC) as neoadjuvant therapy for muscle-invasive bladder cancer (MIBC)
    Meeting Abstract

    Galsky, M. D.; Harshman, L. C.; Crabb, S. J.; Wong, Y. N.; Yu, E. Y.; Chowdhury, S.; Powles, T.; Pal, S. K.; Moshier, E. L.; Ladoire, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Chemoradiation for locally advanced penile squamous cell carcinoma (PSCC): A multi-institution retrospective study
    Meeting Abstract

    Eigl, B. J.; Pond, G. R.; Milowsky, M. I.; Kollnsky, M. P.; Necchl, A.; Hershman, L. C.; di Lorenzo, G.; Dorff, T. B.; Lee, R. J.; Sonpavde, G.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Impact of prior platinum agent and site of primary in patients with advanced urothelial carcinoma (UC) receiving salvage therapy
    Meeting Abstract

    Sonpavde, G.; Bellmunt, J.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Impact of number of lines of prior chemotherapy in patients (pts) with advanced urothelial carcinoma (UC) receiving salvage therapy
    Meeting Abstract

    Sonpavde, G.; Bellmunt, J.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II study of lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer
    Journal Article

    Tagawa, S. T.; Milowsky, M. I.; Morris, M.; Vallabhajosula, S.; Christos, P.; Akhtar, N. H.; Osborne, J.; Goldsmith, S. J.; Larson, S.; Taskar, N. P.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: The role of the host
    Journal Article

    Gallagher, D. J.; Vijai, J.; Hamilton, R. J.; Ostrovnaya, I.; Iyer, G.; Garcia-Grossman, I. R.; Kim, P. H.; Przybylo, J. A.; Alanee, S.; Riches, J. C.; more...
    Annals of Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of everolimus in metastatic urothelial cancer
    Journal Article

    Milowsky, M. I.; Iyer, G.; Regazzi, A. M.; Al-Ahmadie, H.; Gerst, S. R.; Ostrovnaya, I.; Gellert, L. L.; Kaplan, R.; Garcia-Grossman, I. R.; Pendse, D.; more...
    BJU International (2013)

    Fulltext@MSK | Save